TMJ sufferers: could a simple injection stop the clicking?
NCT ID NCT06403046
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed trial tested two anti-inflammatory drugs, tenoxicam and meloxicam, injected into the jaw joint after a routine washout procedure. The goal was to reduce pain, clicking, and improve mouth opening in 30 adults with a specific type of TMJ disorder. The study compares which drug works better for symptom relief.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Tenoxicam and Meloxicam (anti-inflammatory drugs)
- What this could lead to
- If successful, this could point toward a simple injection-based treatment to ease TMJ pain and clicking without surgery.
- What could go wrong
- This is a small, early-phase trial with only 30 participants, so results may not apply to everyone. The treatment targets symptoms, not the underlying disc position.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TEMPOROMANDIBULAR JOINT DISC DISPLACEMENT, WITH REDUCTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beni-suef university
Banī Suwayf, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.